Dermoscopic assessment of skin toxicities in patients with melanoma during treatment with vemurafenib

INTRODUCTION: The use of vemurafenib in melanoma has improved the survival of patients; however, it is associated with skin toxicities. AIM: To assess skin toxicities by dermoscopy in patients treated with vemurafenib. MATERIAL AND METHODS: Eight patients with BRAF V600 mutation positive metastatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajczykowski, Marcin, Kaminska-Winciorek, Grazyna, Nowara, Elzbieta, Samborska-Plewicka, Marzenna, Giebel, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872245/
https://www.ncbi.nlm.nih.gov/pubmed/29599670
http://dx.doi.org/10.5114/ada.2018.73163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872245/
https://www.ncbi.nlm.nih.gov/pubmed/29599670
http://dx.doi.org/10.5114/ada.2018.73163

Ejemplares similares